Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 15 | 2024 | 99 | 5.420 |
Why?
|
| Intraocular Pressure | 17 | 2023 | 144 | 4.940 |
Why?
|
| Glaucoma | 9 | 2022 | 87 | 3.790 |
Why?
|
| Ocular Hypertension | 5 | 2023 | 26 | 2.270 |
Why?
|
| Retinal Degeneration | 4 | 2024 | 93 | 1.580 |
Why?
|
| Color Vision | 3 | 2020 | 10 | 1.390 |
Why?
|
| Retina | 9 | 2024 | 450 | 1.090 |
Why?
|
| Nerve Degeneration | 2 | 2018 | 121 | 0.990 |
Why?
|
| Optic Nerve Diseases | 2 | 2018 | 88 | 0.960 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 126 | 0.950 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 4415 | 0.910 |
Why?
|
| Virtual Reality | 1 | 2023 | 28 | 0.860 |
Why?
|
| Ophthalmologists | 1 | 2023 | 17 | 0.850 |
Why?
|
| Contrast Sensitivity | 3 | 2020 | 60 | 0.840 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2021 | 38 | 0.840 |
Why?
|
| Color Perception | 1 | 2022 | 15 | 0.770 |
Why?
|
| Dark Adaptation | 3 | 2016 | 38 | 0.730 |
Why?
|
| Amacrine Cells | 2 | 2020 | 36 | 0.720 |
Why?
|
| Adaptation, Ocular | 1 | 2020 | 17 | 0.700 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 102 | 0.700 |
Why?
|
| Light | 2 | 2020 | 176 | 0.690 |
Why?
|
| Capillaries | 1 | 2020 | 66 | 0.690 |
Why?
|
| Retinal Vessels | 1 | 2020 | 75 | 0.670 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 210 | 0.670 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 163 | 0.650 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 155 | 0.630 |
Why?
|
| Vision, Ocular | 1 | 2019 | 122 | 0.580 |
Why?
|
| Trabeculectomy | 2 | 2020 | 17 | 0.570 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 97 | 0.570 |
Why?
|
| Neuroprotection | 1 | 2018 | 27 | 0.570 |
Why?
|
| Drosophila Proteins | 7 | 2008 | 713 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 4419 | 0.550 |
Why?
|
| Optic Nerve | 1 | 2018 | 114 | 0.530 |
Why?
|
| Action Potentials | 2 | 2019 | 502 | 0.520 |
Why?
|
| Photoreceptor Cells, Invertebrate | 5 | 2008 | 58 | 0.520 |
Why?
|
| Nerve Fibers | 4 | 2024 | 74 | 0.510 |
Why?
|
| Tonometry, Ocular | 5 | 2022 | 31 | 0.510 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 93 | 0.500 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 1283 | 0.500 |
Why?
|
| ErbB Receptors | 3 | 2007 | 284 | 0.500 |
Why?
|
| Tomography, Optical Coherence | 6 | 2024 | 522 | 0.490 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 11 | 0.490 |
Why?
|
| Paraproteinemias | 1 | 2015 | 16 | 0.480 |
Why?
|
| Cell Count | 4 | 2016 | 254 | 0.450 |
Why?
|
| Animals | 24 | 2020 | 34367 | 0.450 |
Why?
|
| Filtering Surgery | 1 | 2013 | 5 | 0.430 |
Why?
|
| Silver | 1 | 2013 | 21 | 0.420 |
Why?
|
| Mice | 12 | 2020 | 17739 | 0.420 |
Why?
|
| Eye Diseases | 2 | 2025 | 119 | 0.410 |
Why?
|
| Metal Nanoparticles | 1 | 2013 | 42 | 0.410 |
Why?
|
| Transcription Factors | 6 | 2008 | 2603 | 0.410 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 71 | 0.410 |
Why?
|
| Drosophila melanogaster | 5 | 2006 | 771 | 0.400 |
Why?
|
| Transcriptome | 1 | 2019 | 979 | 0.400 |
Why?
|
| Electroretinography | 3 | 2018 | 115 | 0.360 |
Why?
|
| Retinal Diseases | 1 | 2013 | 172 | 0.340 |
Why?
|
| Female | 20 | 2024 | 67028 | 0.300 |
Why?
|
| Night Vision | 2 | 2020 | 5 | 0.300 |
Why?
|
| Eye | 4 | 2006 | 227 | 0.290 |
Why?
|
| Ectropion | 1 | 2007 | 8 | 0.290 |
Why?
|
| Quinazolines | 1 | 2007 | 176 | 0.260 |
Why?
|
| Internship and Residency | 1 | 2016 | 1184 | 0.250 |
Why?
|
| Cell Differentiation | 6 | 2006 | 1913 | 0.250 |
Why?
|
| Cell Survival | 2 | 2020 | 820 | 0.250 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 247 | 0.240 |
Why?
|
| Drosophila | 3 | 2008 | 776 | 0.230 |
Why?
|
| Weightlessness | 1 | 2025 | 46 | 0.230 |
Why?
|
| Skin | 1 | 2007 | 519 | 0.230 |
Why?
|
| Pupa | 1 | 2004 | 21 | 0.230 |
Why?
|
| Vision Disorders | 2 | 2017 | 211 | 0.220 |
Why?
|
| Papilledema | 1 | 2025 | 78 | 0.220 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2014 | 106 | 0.220 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 663 | 0.220 |
Why?
|
| Axial Length, Eye | 2 | 2014 | 49 | 0.210 |
Why?
|
| Space Flight | 1 | 2025 | 107 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 875 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 548 | 0.210 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 2060 | 0.200 |
Why?
|
| Male | 14 | 2024 | 61807 | 0.200 |
Why?
|
| Biomarkers | 3 | 2019 | 3097 | 0.200 |
Why?
|
| Acceleration | 1 | 2022 | 26 | 0.190 |
Why?
|
| Macula Lutea | 1 | 2022 | 45 | 0.190 |
Why?
|
| Color | 1 | 2022 | 31 | 0.190 |
Why?
|
| Physician's Role | 1 | 2023 | 168 | 0.190 |
Why?
|
| Peripheral Nervous System | 1 | 2002 | 42 | 0.190 |
Why?
|
| Insect Proteins | 1 | 2001 | 101 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2004 | 680 | 0.180 |
Why?
|
| Neuronal Outgrowth | 1 | 2020 | 2 | 0.180 |
Why?
|
| Puromycin | 1 | 2020 | 11 | 0.180 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 58 | 0.180 |
Why?
|
| Ophthalmology | 1 | 2023 | 198 | 0.180 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2020 | 8 | 0.180 |
Why?
|
| beta-Alanine | 1 | 2020 | 8 | 0.180 |
Why?
|
| Corneal Edema | 1 | 2020 | 14 | 0.180 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 77 | 0.180 |
Why?
|
| Benzoates | 1 | 2020 | 20 | 0.180 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 53 | 0.170 |
Why?
|
| Humans | 23 | 2025 | 125744 | 0.170 |
Why?
|
| Electrophysiology | 1 | 2020 | 271 | 0.170 |
Why?
|
| Photic Stimulation | 1 | 2020 | 225 | 0.160 |
Why?
|
| Epithelium, Corneal | 1 | 2020 | 173 | 0.150 |
Why?
|
| Suppression, Genetic | 2 | 1995 | 43 | 0.150 |
Why?
|
| Gout | 1 | 2021 | 148 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1713 | 0.150 |
Why?
|
| Veterans | 2 | 2021 | 1748 | 0.140 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 259 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 27 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 396 | 0.140 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 415 | 0.140 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 31 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1701 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2001 | 824 | 0.130 |
Why?
|
| Cell Death | 2 | 2017 | 241 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 372 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 249 | 0.130 |
Why?
|
| Genes, src | 2 | 1995 | 4 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 239 | 0.120 |
Why?
|
| Thymus Hormones | 1 | 1995 | 2 | 0.120 |
Why?
|
| Photophobia | 1 | 2015 | 9 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2018 | 875 | 0.120 |
Why?
|
| Retinal Neurons | 1 | 2015 | 12 | 0.120 |
Why?
|
| Tubulin | 1 | 2015 | 103 | 0.120 |
Why?
|
| Sensory Thresholds | 1 | 2014 | 35 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3058 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 1995 | 64 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2004 | 4595 | 0.120 |
Why?
|
| Visual Fields | 1 | 2015 | 133 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 359 | 0.110 |
Why?
|
| Middle Aged | 8 | 2024 | 27002 | 0.110 |
Why?
|
| Aged | 9 | 2024 | 19897 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 197 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 349 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 670 | 0.110 |
Why?
|
| Blister | 1 | 2013 | 22 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1077 | 0.110 |
Why?
|
| Mitomycin | 1 | 2013 | 49 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2013 | 139 | 0.100 |
Why?
|
| Biotin | 1 | 2013 | 45 | 0.100 |
Why?
|
| Viral Proteins | 1 | 1995 | 347 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 1006 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 128 | 0.100 |
Why?
|
| Rabbits | 1 | 2013 | 718 | 0.100 |
Why?
|
| Axons | 1 | 2015 | 369 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 6609 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 1175 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1021 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 1711 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2017 | 722 | 0.090 |
Why?
|
| Algorithms | 1 | 2017 | 1633 | 0.090 |
Why?
|
| Eye Neoplasms | 1 | 2010 | 50 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 32 | 0.090 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2010 | 48 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 1705 | 0.080 |
Why?
|
| Phenotype | 2 | 2018 | 4271 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1009 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2090 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 144 | 0.080 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 14 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2023 | 16435 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 51 | 0.070 |
Why?
|
| Streptococcus pyogenes | 2 | 1998 | 76 | 0.070 |
Why?
|
| Adult | 6 | 2024 | 29759 | 0.070 |
Why?
|
| Karyopherins | 1 | 2006 | 36 | 0.070 |
Why?
|
| Cicatrix | 1 | 2007 | 124 | 0.060 |
Why?
|
| Streptococcal Infections | 2 | 1998 | 241 | 0.060 |
Why?
|
| Mutation | 5 | 2008 | 5907 | 0.060 |
Why?
|
| Metamorphosis, Biological | 1 | 2004 | 7 | 0.060 |
Why?
|
| Astronauts | 1 | 2025 | 45 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3436 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 154 | 0.050 |
Why?
|
| Bimatoprost | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cloprostenol | 1 | 2023 | 4 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 79 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 2023 | 91 | 0.050 |
Why?
|
| Amides | 1 | 2023 | 89 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2003 | 219 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2004 | 352 | 0.050 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2022 | 16 | 0.050 |
Why?
|
| Syndrome | 1 | 2025 | 1121 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 3894 | 0.050 |
Why?
|
| Neuroglia | 1 | 2004 | 206 | 0.050 |
Why?
|
| Animals, Genetically Modified | 3 | 2008 | 312 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 556 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 51 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 190 | 0.050 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 5 | 0.040 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 10 | 0.040 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2020 | 19 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 561 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1014 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 3108 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2020 | 100 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6173 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 516 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1995 | 120 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2020 | 216 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1127 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 1659 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1995 | 461 | 0.030 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2020 | 342 | 0.030 |
Why?
|
| Tertiary Healthcare | 1 | 2017 | 21 | 0.030 |
Why?
|
| Carrier State | 1 | 1997 | 76 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2008 | 299 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2020 | 816 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 572 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1995 | 56 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 1995 | 9 | 0.030 |
Why?
|
| Cations | 1 | 2015 | 39 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1995 | 39 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 63 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 1995 | 9 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1995 | 18 | 0.030 |
Why?
|
| Retinal Bipolar Cells | 1 | 2015 | 38 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2015 | 63 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1995 | 114 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 240 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 394 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3313 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 211 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 1942 | 0.030 |
Why?
|
| Collagen | 1 | 1995 | 320 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1995 | 237 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2918 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 1186 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1902 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 452 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 1592 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 37 | 0.020 |
Why?
|
| Retinal Hemorrhage | 1 | 2010 | 23 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2905 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 114 | 0.020 |
Why?
|
| Paraplegia | 1 | 2010 | 95 | 0.020 |
Why?
|
| Retinal Detachment | 1 | 2010 | 83 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1469 | 0.020 |
Why?
|
| Risk Factors | 2 | 2021 | 10341 | 0.020 |
Why?
|
| Proteins | 1 | 1995 | 1038 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 2010 | 120 | 0.020 |
Why?
|
| DNA Probes | 1 | 2008 | 123 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 1763 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 122 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2008 | 123 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1998 | 92 | 0.020 |
Why?
|
| Serotyping | 2 | 1998 | 178 | 0.020 |
Why?
|
| Minnesota | 2 | 1998 | 133 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2008 | 217 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 1242 | 0.020 |
Why?
|
| Cilia | 1 | 2006 | 73 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 2714 | 0.020 |
Why?
|
| Rhodopsin | 1 | 2004 | 64 | 0.010 |
Why?
|
| Larva | 1 | 2004 | 248 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 295 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1536 | 0.010 |
Why?
|
| United States | 1 | 2017 | 10938 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1641 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3603 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1998 | 27 | 0.010 |
Why?
|
| Pharyngitis | 1 | 1997 | 32 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 155 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 264 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1997 | 210 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1997 | 405 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 35 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 475 | 0.010 |
Why?
|
| Genes, ras | 1 | 1995 | 100 | 0.010 |
Why?
|
| Schools | 1 | 1997 | 219 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 1997 | 320 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 665 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 3727 | 0.000 |
Why?
|
| Child | 1 | 1997 | 24608 | 0.000 |
Why?
|